NCT00482170View on ClinicalTrials.gov

Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

PHASE3CompletedINTERVENTIONAL

Enrollment

421

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

September 30, 2009

Conditions

Psoriasis

Interventions

DEVICE

Enbrel (etanercept)

Arm 1 = Enbrel 50 mg Prefilled Syringe twice weekly

DEVICE

Etanercept

Arm 2 = Enbrel 50 mg Autoinjector twice weekly

Trial Locations (78)

10435

Berlin

10827

Berlin

14004

Córdoba

17475

Greifswald

18012

Granada

20122

Milan

20246

Hamburg

21013

Gallarate

22100

Como

23538

Lübeck

31059

Toulouse

33600

Pessac

34000

Montpellier

37099

Göttingen

39008

Santander

40128

Bologna

41459

Gothenburg

44093

Nantes

45332

Ioannina

46015

Valencia

48149

Münster

48249

Dülmen

50931

Cologne

51092

Reims

53105

Bonn

54000

Nancy

54644

Athens

Thessaloniki

55101

Mainz

56126

Pisa

65199

Wiesbaden

68135

Mannheim

69495

Pierre-Bénite

71013

S. Giovanni Rotondo

72037

Le Mans

72076

Tübingen

75010

Paris

79106

Freiburg im Breisgau

80131

Napoli

80132

Napoli

80802

München

86179

Augsburg

87042

Limoges

91052

Erlangen

97070

Würzburg

08000

Bruges

01070

Brussels

01200

Brussels

B-2650

Edegem

09000

Ghent

03500

Hasselt

02950

Kapellen

B-4000

Liège

02900

Hellerup

02970

Hørsholm

04000

Roskilde

00029 HUS

Helsinki

00250

Helsinki

802 10

Joensuu

FIN-33521

Tampere

01307

Dresden

D-97080

Würzburg

Unknown

Athens

Padua

06720

Szeged

ITALY 04019

Terracina

01012

Capranica

4818 CK

Breda

4382 EE

Flushing

06525

Nijmegen

05021

Bergen

04068

Stavanger

N-9038

Tromsø

03203

Elche

SPAIN 28046

Madrid

182 88

Danderyd

SE-581 85

Linköping

SE-205 02

Malmo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY